A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy
7 Hills Pharma, LLC
7 Hills Pharma, LLC
Pfizer
Obsidian Therapeutics, Inc.
M.D. Anderson Cancer Center
Filamon LTD
Mayo Clinic
Ankyra Therapeutics, Inc
Washington University School of Medicine
University of Florida
University of Nebraska